John Maher | Chief Scientific Officer
Leucid Bio

John Maher, Chief Scientific Officer, Leucid Bio

Dr John Maher is a clinical immunologist and immunopathologist who leads the "CAR Mechanics" research group within King's College London. His research group is focused on the development of adoptive immunotherapy using CAR engineered and gamma delta T-cells. He is also chief scientific officer of a spin-out company named Leucid Bio. In addition, he is a consultant immunologist within King's Health Partners and Eastbourne Hospital.


Conference Day 1 - Tuesday 31st March 2020 @ 17:00

CAR T-cell immunotherapy of solid tumours: parallel learning from the clinic and lab

last published: 05/Mar/20 17:05 GMT

back to speakers